Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02354131 |
|---|---|
| Brief Title: | Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA) |
| First Submitted : | January 25, 2015 |
| First Submitted that Met QC Criteria : | February 2, 2015 |
| First Posted : | February 3, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 29, 2022 |
| Last Update Posted : | August 30, 2022 |